Our Experts

At NDA we’re a team of experts – experts in the regulated disciplines, and experts in drug development.

Some of us have attained our experience from working inside regulatory authorities, carefully assessing the benefits and risks of new treatments. Some of us have worked for years in the biotech and pharmaceutical industry, patiently developing life changing products for patients suffering from debilitating and sometimes deadly diseases and conditions.

Whatever our background, we share a passion for the art and science of drug development and for making a difference to the clients and the patients we ultimately serve.

Get to know the people behind the passion – read more about our incredible team below.


Dr Björn Carlsson

Advisory Board Member
Expert in non-clinical development and ATMPs

Dr Frits Lekkerkerker

Advisory Board Member
Expert in regulatory affairs and clinical medicine

Dr Kurt Stoeckli

Advisory Board President
Expert in biopharmaceutical R&D strategy and operational management

Dr Laurie Smaldone Alsup

Chief Medical And Scientific Officer
Expert in clinical development and regulatory strategy

Dr Margaret Mitrane

Advisory Board Member
Expert on FDA drug and biologics approval processes

Dr Mary Teeling

Advisory Board Member
Expert in clinical development and market authorisation applications

Dr Olca Huijsmans

Senior Consultant
Expert in regulatory strategy for Phase I-IV drug development

Dr Roz Cox

Principal Consultant
Expert in European and Global Regulatory Affairs

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.